Evidence map›Paper›PMID 37764987›Full record

ArticlePathogens (Basel, Switzerland)2023

Bacteriophage Bioengineering: A Transformative Approach for Targeted Drug Discovery and Beyond.

Longzhu Cui, Srivani Veeranarayanan, Kanate Thitiananpakorn, Dhammika Leshan Wannigama

Abstract readEditorial
In one paragraph

Article in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Characterization of aFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Longzhu CuiDivision of Bacteriology, Department of Infection and Immunity, School of Medicine, Jichi Medical University, Tochigi 329-0498, Japan.ORCID 0000-0002-8909-3885
Srivani VeeranarayananDivision of Bacteriology, Department of Infection and Immunity, School of Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
Kanate ThitiananpakornDivision of Bacteriology, Department of Infection and Immunity, School of Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
Dhammika Leshan WannigamaDepartment of Infectious Diseases and Infection Control, Yamagata Prefectural Central Hospital, Yamagata 990-2292, Japan.ORCID 0000-0001-6316-1221

Funding

AMED JP21gm1610002 and JP22ae0121045
6 · The paper itself

Abstract

Bacteriophages, the viruses that infect and replicate within bacteria, have long been recognized as potential therapeutic agents against bacterial infections [...].

Identifiers

PMID37764987
PMCPMC10534869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.